Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,408Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Eli Lilly

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LASMIDITAN SUCCINATE

Brand Name : REYVOW

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 50MG BASE

Packaging :

Approval Date : 2020-01-31

Application Number : 211280

Regulatory Info : RX

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LASMIDITAN SUCCINATE

Brand Name : REYVOW

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2020-01-31

Application Number : 211280

Regulatory Info : RX

Registration Country : USA

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LASMIDITAN SUCCINATE

Brand Name : REYVOW

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Packaging :

Approval Date : 2020-12-18

Application Number : 211280

Regulatory Info : DISCN

Registration Country : USA

blank